Finance

Share of U.S. companies in China looking to relocate hits a record high, survey finds

Published

4 months ago

January 23, 2025

Chinese and U.S. flags flutter near The Bund, before U.S. trade delegation meet their Chinese counterparts for talks in Shanghai, China July 30, 2019.

Aly Song | Reuters

BEIJING — A record share of U.S. companies in China are accelerating their plans to relocate manufacturing or sourcing, according to a business survey released Thursday.

About 30% of the respondents considered or started such diversification in 2024, surpassing the prior high of 24% in 2022, according to annual surveys from the American Chamber of Commerce in China.

That also exceeded the 23% share reported for 2017, when U.S. President Donald Trump began his first term and started raising tariffs on Chinese goods.

In addition to U.S.-China tensions, “one of the major impacts that we’ve seen in the last five years was Covid and how China closed itself off from the world because of Covid,” Michael Hart, Beijing-based president of AmCham China, told reporters Thursday.

“That’s been one of the largest triggers as people realized they needed to diversify their supply chains,” he said. “I don’t see that trend slowing down.”

China restricted international travel and locked down parts of the country during the Covid-19 pandemic in an attempt to restrict the spread of the disease.

The yuan tends to be 'very sensitive' to trade negotiations, JPMorgan strategist says

While India and Southeast Asian countries remained the most popular destination for relocating production, the survey showed 18% of the respondents considered relocating to the U.S. in 2024, up from 16% the prior year.

The majority of U.S. companies did not plan to diversify. Just over two-thirds, or 67%, of respondents said they were not considering relocating manufacturing, a 10 percentage point drop from 2023, the survey showed.

The latest AmCham China survey covered 368 members from Oct. 21 to Nov. 15. Trump was re-elected U.S. president on Nov. 5.

Trump this week affirmed plans to raise tariffs on Chinese goods by 10%, and said the duties could come as soon as Feb. 1. That follows an increasingly tough U.S. stance on China. The Biden administration had emphasized the U.S. is in competition with China and issued sweeping restrictions on the ability of Chinese companies to access high-end U.S. tech.

More than 60% of the respondents said U.S.-China tensions were the biggest challenge for doing business in China in the year ahead. Competition from local state-owned companies or privately owned Chinese companies was the second-biggest challenge for U.S. businesses operating in China, according to the survey.

Slower economic growth

Adding to geopolitical pressures, growth in the world’s second-largest economy has slowed, with muted consumer spending since the pandemic. Chinese authorities in late September started ramping up efforts to stimulate growth and halt the real estate slump.

For a third-straight year, more than half of AmCham China respondents said they did not make a profit in the country, adding that the region had become less competitive in terms of margins versus other global markets.

The proportion of companies no longer listing China as a preferred investment destination climbed to 21%, doubling from pre-pandemic levels, the survey said.

Looking ahead, however, tech, industrial and consumer businesses said they viewed growth in domestic consumption as the top business opportunity for 2025, the survey said. Services firms said their top opportunity was Chinese companies looking to expand overseas.

Hart noted that many members are still optimistic on Chinese consumers as a “sizeable, important market.”

Finance

Insiders at UnitedHealth are scooping up tarnished shares

Published

2 days ago

May 16, 2025

Business Finance News

Key Points

UnitedHealth Group saw some of its insiders step in and purchase declining shares this week.
Kristen Gil, a director at the firm, bought 3,700 shares worth roughly $1 million on Thursday.
Shares of UnitedHealth plunged nearly 11% to $274.35 on Thursday following a report in The Wall Street Journal that the Department of Justice is conducting a criminal investigation into possible Medicare fraud.

Finance

Federal Reserve will reduce staff by 10% in coming years, Powell memo says

Published

2 days ago

May 16, 2025

Business Finance News

U.S. Federal Reserve in Washington, DC, on January 30, 2024.

Mandel Ngan | Afp | Getty Images

The Federal Reserve will look to reduce its headcount by 10% over the next couple of years, including offering deferred resignation to some older employees, central bank chair Jerome Powell said in a memo.

“Experience here and elsewhere shows that it is healthy for any organization to periodically take a fresh look at its staffing and resources. The Fed has done that from time to time as our work, priorities, or external environment have changed,” Powell said in a memo obtained by CNBC.

The central bank chief added that he has instructed leaders throughout the Fed “to find incremental ways to consolidate functions where appropriate, modernize some business practices, and ensure that we are right-sized and able to meet our statutory mission.” One method for shrinking the staff will be to offer a voluntary deferred resignation program to employees of the Federal Reserve Board who would be fully eligible to retire at the end of 2027.

The central bank said in its 2023 annual report that it had just under 24,000 employees. A 10% reduction would bring that number below 22,000.

The memo comes as the Trump administration has pushed for cost cuts across civil service agencies, spearheaded by Elon Musk and the so-called Department of Government Efficiency. Musk has previously called the Fed “absurdly overstaffed.” Powell’s memo did not mention Musk or DOGE as a factor in the decision to shrink headcount.

The planned staff cuts were first reported by Bloomberg News.

— CNBC’s Matt Cuddy contributed reporting.